|
Dealings in securities by associates of directors
Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
Listed on the General Segment of the Main Board
("Ascendis Health" or "the Company")
DEALINGS IN SECURITIES BY ASSOCIATES OF DIRECTORS
In compliance with paragraphs 3.63 to 3.74 of the Listings Requirements of the JSE Limited
("Listings Requirements"), the following information regarding the dealings in securities is
disclosed:
1.
Name of director Carl Neethling
Name of company of which the director is a Ascendis Health Limited
director
Date of transaction 5 June 2025
Price per security (Cents) 80.00
Number of securities 33 661
Total rand value of securities R26 928.80
Class of securities Ordinary Shares
Nature of transaction Purchase of shares by an associate of the
director (on-market transaction)
Nature and extent of directors interest in the Indirect, beneficial
transaction
Name of associate ACN Capital (Pty) Ltd
Relationship with director Director is the ultimate controlling
shareholder of the associate
2.
Name of director Theunis de Bruyn
Name of company of which the director is a Ascendis Health Limited
director
Date of transaction 5 June 2025
Price per security (Cents) 80.00
Number of securities 33 661
Total rand value of securities R26 928.80
Class of securities Ordinary shares
Nature of transaction Purchase of shares by an associate of the
director (on-market transaction)
Nature and extent of directors interest in the Indirect, beneficial
transaction
Name of associate Calibre Investment Holdings (Pty) Ltd
Relationship with director Director is a director and a shareholder of
the associate
Clearance for the above was obtained in terms of paragraph 3.66 of the Listings Requirements.
Johannesburg
11 June 2025
Sponsor
Valeo Capital (Pty) Limited
Date: 11-06-2025 12:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS. |
|